- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 1, 2026 | 38.64M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 42.27M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 41.45M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $327.81K |
| Capex | Q1 2026 · Mar 31, 2025 | $670.69K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$2.2M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$2.68M |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $2.73M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $2.73M |
| Short Term Investments | Q1 2026 · Mar 31, 2026 | $4.3M |
| Short Term Investments | Q1 2026 · Dec 31, 2025 | $4.26M |
| Short Term Investments restated | Q1 2026 · Mar 31, 2025 | $4.3M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $11.4M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $14.13M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $9M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $11.4M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $21.69M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $24.71M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $9.39M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $8.35M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $27.75M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $27.23M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $25.66M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $27.56M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $36.75M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $38.64M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.07 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.08 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.07 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.08 |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $1.62M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $1.79M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$3.01M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$3.47M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$3.16M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$3.52M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $6.9M |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $6.61M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $3.21M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $3.22M |
| Revenue | Q1 2026 · Mar 31, 2026 | $10.11M |
| Revenue | Q1 2026 · Mar 31, 2025 | $9.83M |